In case you missed it: June 27 to July 1

Article

A look back at the week's news.

Not just abortion: How the demise of Roe v Wade may impact fertility care

As we were going to press with the July issue, the United States Supreme Court overturned Roe v Wade, eliminating the constitutional right to an abortion, and leaving the question of abortion rights to the states.

Pharmacies limiting Plan B purchases after Roe v. Wade reversal

The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.

HHS secretary details department’s efforts to protect reproductive health care

“The impact was visible and real,” said Xavier Becerra, secretary of the US Department for Health and Human Services during a press conference Tuesday.

SOGH responds to Roe v Wade decision

The Society of Ob/Gyn Hospitalists released a statement on the Supreme Court Decision overturning Roe v Wade.


Recent Videos
Non-hormonal treatments offer relief for genitourinary syndrome of menopause | Image Credit: providers.uthscsa.edu.
Laxmi Gannu, MD, notes PPD screening gaps and adverse outcomes | Image Credit: linkedin.com.
Jill Liss, MD, MSCP, FACOG, associate clinical professor, OB/GYN, at the University of Colorado School of Medicine.
Elizabeth Mollard, PhD, WHNP, CNM
Victoria Wang, MD, discusses surveillance for high-grade dysplasia | Image Credit: account.allinahealth.org.
Farah Amro, MD
Laurence Shields, MD, is System Physician Vice President at the Women and Infants Clinical Institute with CommonSpirit Health in Santa Maria, California.
Chemen M. Neal, MD, discusses weekly secnidazole for bacterial vaginosis treatment | Image Credit: medicine.iu.edu
Joy Baker, MD, FACOG, highlights how to recognize PPD | Image Credit: linkedin.com.
Baher Mankabady, MD, highlights safety of buprenorphine against OUD in pregnancy | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.